Skip to main content
RYTM logo

Rhythm Pharmaceuticals, Inc.

RYTMNASDAQHealthcareBiotechnology

$89.47Today:- (-)1Y −16.70%

As of Oct 26, 2026 close

Market cap
$6.14B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$74.50$122.20
Volume (live)
-
Avg. volume (3M)
734.55K

Rhythm Pharmaceuticals, Inc. (RYTM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Rhythm Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 16 professional research analysts

Consensus Rating

Buy
Based on 16 unique analysts
(24 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$146.64
+59.08% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest RYTM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Seamus Fernandez
Guggenheim
BuyReiterates
$143.00
Sharon Zackfia
William Blair
BuyInitiates
$206.00
Priyanka Grover
JP Morgan
BuyReiterates
$146.00 → $145.00
Samantha Semenkow
Citi
BuyReiterates
$143.00
Ram Selvaraju
HC Wainwright
BuyReiterates
$105.00 → $130.00
Tazeen Ahmad
BofA Securities
BuyReiterates
$149.00 → $150.00
Lisa Walter
RBC Capital
BuyReiterates
$155.00 → $159.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Kalpit Patel
Wolfe Research
BuyInitiates
-
Priyanka Grover
JP Morgan
BuyReiterates
-
Lisa Walter
RBC Capital
BuyMaintains
$155.00
Basma Radwan
Leerink Partners
BuyInitiates
$133.00
David Hoang
Deutsche Bank
HoldInitiates
$120.00
David Hoang
Deutsche Bank
HoldInitiates
$120.00
Seamus Fernandez
Guggenheim
BuyReiterates
$143.00
Michael Ulz
Morgan Stanley
BuyReiterates
$150.00
Seamus Fernandez
Guggenheim
BuyReiterates
$143.00
Michael Ulz
Morgan Stanley
BuyReiterates
$150.00
Jonathan Wolleben
Citizens JMP
BuyMaintains
$155.00 → $160.00
Whitney Ijem
Canaccord Genuity
BuyMaintains
$151.00 → $154.00
Samantha Semenkow
Citi
BuyMaintains
$142.00 → $143.00
Phil Nadeau
TD Cowen
BuyInitiates Coverage
$130.00
Tazeen Ahmad
BofA Securities
BuyReiterates
$149.00
Joseph Stringer
Needham
BuyMaintains
$130.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 19, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for RYTM?

The analyst consensus rating for RYTM is Buy, based on the latest ratings from 16 analysts over the last 90 days.

What is the average price target for RYTM?

The average 12-month price target for RYTM is $146.64, representing an upside of 59.1% from the Oct 27, 2026 close of $92.18.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.